Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Science. 2004 Mar 19;303(5665):1818-22.

Drug delivery systems: entering the mainstream.

Author information

  • 1Department of Pharmacology, University of Alberta, Edmonton T6G 2H7, Canada. terry.allen@ualberta.ca

Abstract

Drug delivery systems (DDS) such as lipid- or polymer-based nanoparticles can be designed to improve the pharmacological and therapeutic properties of drugs administered parenterally. Many of the early problems that hindered the clinical applications of particulate DDS have been overcome, with several DDS formulations of anticancer and antifungal drugs now approved for clinical use. Furthermore, there is considerable interest in exploiting the advantages of DDS for in vivo delivery of new drugs derived from proteomics or genomics research and for their use in ligand-targeted therapeutics.

PMID:
15031496
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for HighWire
    Loading ...
    Write to the Help Desk